Capivasertib in Hormone Receptor–Positive Advanced Breast Cancer
New England Journal of Medicine · 2023-06 · 388 (22) · 2058-2070
DOI: 10.1056/nejmoa2214131 ↗Kurz gefasst
Klinische Studie (Phase III) in der Zeitschrift New England Journal of Medicine, 2023-06. Verfasst von Nicholas C Turner und 23 weiteren Autor:innen. Beteiligte Einrichtung: From the Royal Marsden Hospital, Institute of Cancer Research, London (N.C.T.), the Christie NHS Foundation Trust, Manchester (S.J.H.), and Oncology …. Hauptthemen laut MEDLINE: Aromatase Inhibitors, Breast Neoplasms. Die Arbeit wurde bisher 853-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, AstraZeneca.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Royal Marsden Hospital, Institute of Cancer Research, London (N.C.T.), the Christie NHS Foundation Trust, Manchester (S.J.H.), and Oncology Research and Development, AstraZeneca, Cambridge (E.C.B., L.G., G.S.,…
ORCID-Profile: Javier Cortes, Joohyuk Sohn
Förderung
- NCI NIH HHS
- AstraZeneca
Zitieren
APA
Turner, N. C., Oliveira, M., Howell, S. J., Dalenc, F., Cortes, J., Gomez Moreno, H. L., Hu, X., Jhaveri, K., Krivorotko, P., Loibl, S., Morales Murillo, S., Okera, M., Park, Y. H., Sohn, J., Toi, M., Tokunaga, E., Yousef, S., Zhukova, L., de Bruin, E. C., …, & CAPItello-291 Study Group (2023). Capivasertib in Hormone Receptor–Positive Advanced Breast Cancer. New England Journal of Medicine, 388(22), 2058-2070. https://doi.org/10.1056/nejmoa2214131
Vancouver
Turner NC, Oliveira M, Howell SJ, Dalenc F, Cortes J, Gomez Moreno HL, et al. Capivasertib in Hormone Receptor–Positive Advanced Breast Cancer. New England Journal of Medicine. 2023;388(22):2058-2070. doi:10.1056/nejmoa2214131
BibTeX
@article{Turner2023,
author = {Turner, Nicholas C and Oliveira, Mafalda and Howell, Sacha J and Dalenc, Florence and Cortes, Javier and Gomez Moreno, Henry L and Hu, Xichun and Jhaveri, Komal and Krivorotko, Petr and Loibl, Sibylle and Morales Murillo, Serafin and Okera, Meena and Park, Yeon Hee and Sohn, Joohyuk and Toi, Masakazu and Tokunaga, Eriko and Yousef, Samih and Zhukova, Lyudmila and de Bruin, Elza C and Grinsted, Lynda and Schiavon, Gaia and Foxley, Andrew and Rugo, Hope S and CAPItello-291 Study Group, CAPItello-291 Study Group},
title = {Capivasertib in Hormone Receptor–Positive Advanced Breast Cancer},
journal = {New England Journal of Medicine},
year = {2023},
volume = {388},
number = {22},
pages = {2058--2070},
doi = {10.1056/nejmoa2214131}
}
EUVIMED